Tag:
settlement
Latest Headlines
Latest Headlines
Pfizer to pay $3.3M to settle Zyvox probe
Pfizer ( $PFE ) is again facing trouble over promotions of one of its drugs. The pharma giant has agreed to fork over $3.34 million to Oregon for deceptive marketing claims related to the antibiotic Zyvox following a two-year investigation.
Medicines Company, APP settlement includes manufacturing agreement
A fill/finish manufacturing agreement is part of the settlement between The Medicines Co. ($MDCO) and APP Pharmaceuticals ( $APPX ) over generic versions of The Medicines Co.'s lead product, Angiomax.
Watson, Sandoz settle Medicaid whistleblower suits for $145M
Watson Pharmaceuticals ( $WPI ) and Novartis' ( $NVS ) generics unit Sandoz have agreed to settle False Claims Act lawsuits alleging they overstated the prices on drugs sold to Medicaid programs. Watson
J&J's Scios to plead guilty, pay $85M in Natrecor case
Johnson & Johnson's ( $JNJ ) legion of legal problems is one less strong. The company agreed to pay $85 million and plead guilty to a misdemeanor charge in a Justice Department probe of its
AZ to pay $2.5M in Idaho Medicaid case
In the latest settlement of a Medicaid pricing lawsuit, AstraZeneca ( $AZN ) agreed to pay $2.5 million to resolve Idaho's claims that it overstated average wholesale prices for various products,
SCOTUS won't look at Wyeth HRT case
The U.S. Supreme Court won't hear an appeal from Pfizer's Wyeth unit of a ruling in a Nevada hormone-therapy lawsuit. The case involved three women who claimed they developed breast cancer after
Pfizer sets aside $772M for settling Prempro cases
Pfizer is the latest drugmaker to disclose a new reserve for legal settlements. The company said in an SEC filing that it has set aside a total of $772 million to cover litigation over its Prempro
J&J earmarks funds to settle Risperdal probe
Johnson & Johnson says it has set aside funds for a potential settlement with the U.S. government. The settlement would resolve an investigation into J&J's marketing of the antipsychotic
GSK poised to settle another 1,000 Avandia suits
GlaxoSmithKline is close to wrapping up another 1,000 Avandia liability suits. As Bloomberg reports, the company is in settlement talks with lawyers representing about 1,000 patients who used Avandia
Serono to pay $44M in U.S. kickbacks case
Another whistleblower lawsuit has ended with a settlement. Merck Serono has agreed to pay $44.3 million to resolve claims that it paid doctors to prescribe its multiple sclerosis drug Rebif, the
